Technical articles
15/12/2021
Discovering our -omics activities
To demystify this area of activity and offer you the opportunity to better understand it, our biostatistics and bioinformatics -om
17/11/2021
The headquarters of Efor Group is moving.
The Lyon-based teams of Efor and CVO-EUROPE are relocating to the brand new premises at Racing Park in Champagne au mont d’o
16/11/2021
Post-Market Surveillance (PMS), Post-Market Clinical Follow-up (PMCF/PMPF) and PMCF/PMPF Studies
Post-Market SurveillanceFor any MD (including IVDMDs) placed on the market, made available on the market or put into service, manu
5/09/2021
Soladis joins the Efor Group, bringing 20 years of expertise in statistics and data management
At the end of 2020, our group joined forces with CVO-EUROPE , a company with over 25 years' experience working with major pharmac
8/01/2021
Efor and CVO Europe join forces to become the european leader in Life Sciences consulting
Efor Group continues its growth journey with the acquisition of CVO Europe
Join our team
Consult our offers
4/02/2020
New trends in medical journals: limited use of p-values in favour of estimated indicators and confidence intervals
Why is the p-value, once so widely used, now being called into question?